One of the reasons I invested in NWBO is because due diligence told me Linda would finish what she started sooner or later because she knew when to shut this trial down then start back up again. Too many CEOs don’t know when to pull the trigger or try to get around it. She did what was needed and brought this company through several very rough seasons. About 9 out of 10 biotechs fail and that failure starts with leadership. Linda is not part of that 90%. When you find a way to recognize this in a positive way I think you will find the grapes suddenly become much sweeter ; ). Best wishes.
Market Data 
Markets 
AI
